fda tirzepatide Grants a New Indication for Obesity Management FDA Approves Mounjaro (tirzepatide) Injection

The 2025 American College of Rheumatology guidelines for SLE treatment and the 2025 EULAR recommendations for lupus nephritis both acknowledge the potential role of metabolic therapies including GLP-1 medications

In typical neonatal cases of PA, symptoms usually appear within hours to days after birth and are often accompanied by acute metabolic disturbances, poor general condition, feeding difficulties, vomiting, dehydration and temperature instability

Why do GLP-1 medications need to stop before surgery

Of clinical relevance, human plasma MIF levels increase post menopause and fall following HRT [57]

B., SOX2Associated Signaling Pathways Regulate Biological Phenotypes of Cancers, Biomedicine & Pharmacotherapy 160 (2023): 114336